Advertisement
Screener

BioNexus Gene Lab Corp. (BGLC) Pre-Tax Margin

BioNexus Gene Lab Corp. (BGLC) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -376.14%.
  • 2026-03-31: Pre-Tax Margin -2379.72%.
  • 2025-12-31: Pre-Tax Margin -214.18%.
  • 2025-09-30: Pre-Tax Margin -27.87%.

Complete source-backed pre-tax margin history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-376.14%
2026-03-31-2379.72%
2025-12-31-214.18%
2025-09-30-27.87%
2025-06-30-27.26%
2025-03-31-29.17%
2024-12-31-16.72%
2024-09-30-51.09%
2024-06-3012.90%
2024-03-31-3.51%
2023-12-3111.16%
2023-09-30-99.18%
2023-06-30-10.72%
2023-03-31-2.23%
2022-12-31-4.49%
2022-09-30-2.61%
2022-06-30-5.64%
2022-03-311.04%
2021-12-316.07%
2021-09-3010.36%
2021-06-304.42%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-40.20%
2024-12-31-16.77%
2023-12-31-26.69%
2022-12-31-2.78%
2021-12-317.80%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aclarion, Inc. (ACON)United States$0.008B
Advanced Biomed Inc. (ADVB)$0.009B
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45